Search

everythinglearnresearchcommunity

for

Search:↓

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Finasteride treatment makes the prostate look more like a healthy one.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

The extract from Clitoria ternatea flowers helps human skin cells grow and promotes hair growth in mice.

Liposomes with butterfly pea extract and clove oil are stable and effective according to users.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5-ARI therapy may help prevent prostate cancer progression.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Finasteride significantly reduces prostate cancer risk.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

BPH management needs better long-term studies and prevention strategies.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Finasteride significantly reduces the risk of prostate cancer.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Improving symptoms of male urinary problems may lower the risk of death.